Rezultati

Review: Targeting the Hedgehog pathway in cancer od Sachin Gupta, Naoko Takebe, Patricia LoRusso

Polni tekst Polni tekst

Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects od Richard Graham, Cornelis E. C. A. Hop, Marie T. Borin, Bert L. Lum, Dawn Colburn, Ilsung Chang, Young G. Shin, Vikram Malhi, Jennifer A. Low, Mark J. Dresser

Polni tekst

Non-Canonical Hh Signaling in Cancer—Current Understanding and Future Directions od Dongsheng Gu, Jingwu Xie

Polni tekst

GLI2 is a novel therapeutic target for metastasis of osteosarcoma od Hiroko Nagao‐Kitamoto, Masahito Nagata, Satoshi Nagano, Sho Kitamoto, Yasuhiro Ishidou, Takuya Yamamoto, Shunsuke Nakamura, Arisa Tsuru, Masahiko Abematsu, Yusuke Fujimoto, Masahiro Yokouchi, Shinichi Kitajima, Takako Yoshioka, Shingo Maeda, Suguru Yonezawa, Setsuro Komiya, Takao Setoguchi

Polni tekst Polni tekst

Midline carcinoma with t(15;19) and BRD4-NUTfusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy od Jens Engleson, Maria Soller, Ioannis Panagopoulos, Anna Dahlén, Michael Dictor, Mats Jerkeman

Polni tekst Polni tekst

Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma od Daniel D. Von Hoff, Patricia LoRusso, Charles M. Rudin, Josina C. Reddy, Robert L. Yauch, Raoul Tibes, Glen J. Weiss, Mitesh J. Borad, Christine L. Hann, Julie R. Brahmer, Howard Mackey, B. Lum, Walter C. Darbonne, James C. Marsters, Frédéric J. de Sauvage, Jennifer A. Low

Polni tekst Polni tekst

Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma od Hayley J. Sharpe, Grégoire Pau, Gerrit J.P. Dijkgraaf, Nicole Basset‐Séguin, Zora Modrušan, Thomas Januario, Vickie Tsui, Alison B. Durham, Andrzej A. Dlugosz, Peter M. Haverty, Richard Bourgon, Jean Y. Tang, Kavita Y. Sarin, Luc Dirix, David C. Fisher, Charles M. Rudin, Howard Sofen, Michael R. Migden, Robert L. Yauch, Frédéric J. de Sauvage

Polni tekst

Concurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma od Erqi L. Pollom, Timothy T. Bui, Anne Lynn S. Chang, A. Dimitrios Colevas, Wendy Hara

Polni tekst Polni tekst

Definition of Critical Periods for Hedgehog Pathway Antagonist-Induced Holoprosencephaly, Cleft Lip, and Cleft Palate od Galen W. Heyne, Cal G. Melberg, Padydeh Doroodchi, Kia F. Parins, Henry W. Kietzman, Joshua L. Everson, Lydia J. Ansen-Wilson, Robert J. Lipinski

Polni tekst Polni tekst

Novel Hedgehog pathway targets against basal cell carcinoma od Jean Y. Tang, Po‐Wah So, E EPSTEINJR

Polni tekst

Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes od Monica Dentice, Cristina Luongo, Stephen A. Huang, Raffaele Ambrosio, Antonia Elefante, Delphine Mirebeau‐Prunier, Ann Marie Zavacki, Gianfranco Fenzi, Marina Grachtchouk, Mark E. Hutchin, Andrzej A. Dlugosz, Antônio C. Bianco, Caterina Missero, P. Reed Larsen, Domenico Salvatore

Polni tekst

Small‐Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics od Stefan Peukert, Karen Miller‐Moslin

Polni tekst Polni tekst

Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma od Anne Lynn S. Chang, Anthony E. Oro

Polni tekst

Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma od Sabrina Pricl, Barbara Cortelazzi, Valentina Dal Col, Domenico Marson, Erik Laurini, Maurizio Fermeglia, Lisa Licitra, Silvana Pilotti, Paolo Bossi, Federica Perrone

Polni tekst

Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma od Edward Kim, Vaibhav Sahai, Ethan V. Abel, Kent A. Griffith, Joel K. Greenson, Naoko Takebe, Gazala Khan, John Blau, Ronald A. Craig, Ulysses J. Balis, Mark M. Zalupski, Diane M. Simeone

Polni tekst Polni tekst

Vismodegib, an antagonist of hedgehog signaling, directly alters taste molecular signaling in taste buds od Hyekyung Yang, Wei‐na Cong, Jeong Seon Yoon, Josephine M. Egan

Polni tekst Polni tekst

A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma od Howard Sofen, Kenneth G. Gross, Leonard H. Goldberg, Harry H. Sharata, Tiffani K. Hamilton, Barbara M. Egbert, Benjamin Lyons, Jeannie Hou, Ivor Caro

Polni tekst

Vismodegib for Periocular and Orbital Basal Cell Carcinoma od Harmeet Gill, Eve E. Moscato, Anne Lynn S. Chang, Seaver L. Soon, Rona Z. Silkiss

Polni tekst Polni tekst

The dawn of hedgehog inhibitors: Vismodegib od Sandhiya Selvarajan, George Melvin, Srinivasamurthy Suresh Kumar, Steven Aibor Dkhar

Polni tekst

Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome od Jean Y. Tang, Julian Mackay‐Wiggan, Michelle Aszterbaum, Robert L. Yauch, Joselyn Lindgren, Kris S. Chang, Carol Coppola, Anita M. Chanana, Jackleen Marji, David R. Bickers, Ervin H. Epstein

Polni tekst Polni tekst